HMGB1 & Infection
Editor Yang-Hua Qin
Ze-Qian Wu, Lei Tan, Wei-Qiang Gan, Zhi-Shuo Mo, Da-Biao Chen, Pei-Pei Wang, Qi-Yi Zhao, Dong-Ying Xie, Zhi-Liang Gao
3 comments on PubPeer • http://www.ncbi.nlm.nih.gov/pubmed/33842635
Dec 20, 2021 - It seems that the abstract was written by a non-medical author. There is no “hepatitis B antigen", and there are two "CD19+++CD40+++" in the results section.
Mingkun Chen, Li Zhu, Miao Xue, Rongrong Zhu, Liling Jing, Huaizhou Wang, Yanghua Qin
http://dx.doi.org/10.1038/s41598-021-84477-2
Sep 22, 2021 - As an immune mediator, HMGB1 is a good biomarker of immune balance status. Fever is a common sign of infection as well as autoimmune diseases. The whole evaluation of HMGB1 and anti-HMGB1 antibodies may provide useful information for physicians to deal with FUO.
Liting Chen, Xiaolu Long, Qian Xu, Jiaqi Tan, Gaoxiang Wang, Yang Cao, Jia Wei, Hui Luo, Hui Zhu, Liang Huang, Fankai Meng, Lifang Huang, Na Wang, Xiaoxi Zhou, Lei Zhao, Xing Chen, Zekai Mao, Caixia Chen, Zhen Li, Ziyong Sun, Jianping Zhao, Daowen Wang, Gang Huang, Wei Wang, Jianfeng Zhou
http://dx.doi.org/10.1038/s41423-020-0492-x
Sep 17, 2021 - As a new infectious disease, the response mode of Acute-phase proteins one is of interesting focus in COVID-19. HMGB1's role in inflammation is unclear, but its potential role in diagnosis and monitoring the therapy effection is widely accepted.
